Abstract: Gadolinium ethoxybenzyl dimeglumine (Gd-EOB-DTPA), a newly applicable hepatocyte specific contrast agent,can provide both dynamic and hepatobiliary images and has been rapidly accepted by clinicians for the diagnosis of liver lesions and preoperative evaluation. Gd-EOB-DTPA can fulfill hepatic perfusion imaging, detection and characterization of focal liver lesions, evaluation of liver function , and predict biological behaviors of hepatocellular carcinoma (HCC) within the same examination in a relatively short time window. A large number of domestic and foreign studies have confirmed that hepatobiliary specific enhanced magnetic resonance imaging (MRI) was significantly superior to MRI scan, enhanced CT and ultrasound in diagnosing HCC. With the help of the advanced imaging techniques, surgeons can accurately diagnose and assess the situation of patients to implement individualized treatment plans, and therefore these will promote the development of precision hepatic surgery.